Novo Nordisk Pharmaceuticals Tucson, AZ - 85749

Novo Nordisk Pharmaceuticals is categorized under Wholesale Pharmaceutical Products in Tucson, AZ and active since 2010.

Novo Nordisk Pharmaceuticals was established in 2010, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Wholesale Pharmaceutical Products business, which does work in the B2B market, and is classified as a Wholesale Pharmaceutical Products, under code number 424210 by the NAICS.

If you are seeking more information, feel free to contact Tom Pothoff at the company’s single location by writing to 1960 North Bonanza Avenue, Tucson, Arizona AZ 85749 or by phoning (520) 760-7995. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Novo Nordisk Pharmaceuticals
Contact Person: Tom Pothoff
Address: 1960 North Bonanza Avenue, Tucson, Arizona 85749
Phone Number: (520) 760-7995
Annual Revenue (USD): $100.000 to $499.999
Founded: 2010
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2B (Business to Business)
Business Category: Wholesale Pharmaceutical Products
SIC Code: 5122
NAICS Code: 424210
Share This Business:

Novo Nordisk Pharmaceuticals was started in 2010 to provide professional Wholesale Pharmaceutical Products under the SIC code 5122 and NAICS code 424210. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.

Feel free to contact Tom Pothoff for inquiries that concern Novo Nordisk Pharmaceuticals by calling the company number (520) 760-7995, as your correspondence is most welcome. Additionally, the physical location of the single location of Novo Nordisk Pharmaceuticals can be found at the coordinates 32.246582,-110.781057 as well as the street address 1960 North Bonanza Avenue in Tucson, Arizona 85749.

For its online presence, you may visit Novo Nordisk Pharmaceuticals’s website at and engage with its social media outlets through on Twitter and on Facebook.